Document Detail

Variation in health care provider definitions of moderate consumption of alcohol as related to recommendations regarding alcohol consumption during pregnancy: results from a Canadian survey.
MedLine Citation:
PMID:  15905798     Owner:  NLM     Status:  MEDLINE    
Women rely on health care providers for general health care and preconception counseling, including advice on alcohol consumption. Definitions of moderate consumption may differ by individual provider, resulting in inconsistency in advice and lack of clarity for patients both before and during pregnancy. The objective of this study was to determine if health care providers' definition of moderate alcohol consumption was associated with advice to pregnant women regarding alcohol use during pregnancy and to describe health care providers' communication regarding alcohol consumption. Between October 2001 and October 2002, a survey was mailed to a national random sample of 3114 Canadian obstetricians and gynecologists, midwives, and family physicians. The main outcome measure was questionnaire responses regarding knowledge and prevention issues related to alcohol and pregnancy as well as provider characteristics. Response rates ranged from 31.1% among family physicians to 63.5% among midwives. Moderate alcohol consumption among nonpregnant women was defined as 1 to 2 drinks per occasion by about 89% of providers and did not relate to recommendations during pregnancy. Those who recommended abstinence during pregnancy were more likely to define moderation as 4 or more occasions per week as compared with those who did not recommend abstinence (P=0.022). Fewer than 50% of providers frequently defined "moderation" for their patients. More family physicians (90.0%) than obstetricians (83.9%) or midwives (81.1%) recommended alcohol abstinence during pregnancy (overall 87.8%, P=0.005). Thus, there is opportunity for providers to appropriately counsel their patients by advising alcohol abstinence during pregnancy and more frequently defining "moderation" for all clients.
Suzanne C Tough; Margaret Clarke; Matt Hicks; Sterling Clarren
Related Documents :
8947608 - Bronchial responsiveness and inflammation in guinea-pigs exposed to toluene diisocyanat...
23267778 - Construction and validation of a placental tissue microarray from specimens of well-doc...
8714868 - A pilot neurodevelopmental study of seychellois children following in utero exposure to...
2776078 - No effect of chronic ethanol administration on the activity of alcohol dehydrogenase an...
10048058 - Application of new electrosurgical devices and probes in endoscopic neurosurgery.
8531098 - L(+)- and d(-)-lactate modulate rat renal tubular accumulation of amantadine in the pre...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Therapeutic drug monitoring     Volume:  27     ISSN:  0163-4356     ISO Abbreviation:  Ther Drug Monit     Publication Date:  2005 Jun 
Date Detail:
Created Date:  2005-05-20     Completed Date:  2005-09-29     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7909660     Medline TA:  Ther Drug Monit     Country:  United States    
Other Details:
Languages:  eng     Pagination:  290-6     Citation Subset:  IM    
Department of Paediatrics, University of Calgary, Calgary, Alberta, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Alcohol Drinking*
Health Personnel*
Health Planning Guidelines
Middle Aged

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association between alopecia and response to chemotherapy in patients with Hodgkin lymphoma.
Next Document:  NAT2*5/*5 genotype (341T>C) is a potential risk factor for schistosomiasis-associated bladder cancer...